Status:
ACTIVE_NOT_RECRUITING
Radiomics of Autism Spectrum Disorder
Lead Sponsor:
Qingling Chen
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
1-14 years
Brief Summary
Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorders including autism.Despite ongoing studies, the pathogenesis of ASD still remains unclear.The global prevalence of ASD wa...
Eligibility Criteria
Inclusion
- （a）healthy subject of same ages;(b)without injury to head and diseases of the nervous system; (c)without family history of mental disorders; (d)without other somatic illness.
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT05439954
Start Date
January 1 2020
End Date
December 1 2024
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fifth Affiliated Hospital at Sun Yat-sen University
Zhuhai, Guangdong, China